Research and Markets (http://www.researchandmarkets.com/research/jh692m/global) has announced the addition of the "Global Testosterone Market Forecast Report, 2016" report to their offering.

One of the main drivers of this market is the increasing global aging population. The number of patients suffering from testosterone deficiency is increasing due to its relatively high prevalence in the elderly population.

Numerous well-known vendors have increased their focus and efforts in R&D toward the development of testosterone replacement products that are more effective, have fewer side effects, and have more potential to enhance testosterone levels. Restoring testosterone levels to normal range improves quality of life in the long term and is beneficial in providing the patient with a range of benefits to his/her muscle and bone and other testosterone-dependent functions. Restoring testosterone levels also increases the body-mass index of the patient. Although testosterone replacement therapies replace the hormone in the body, no study has been conducted to see if the same therapy helps reduce the occurrence of fractures and if the therapy would be able to reach a level of clinical significance. Thorough investigations have not been conducted to ascertain the threshold serum testosterone level needed to avoid morbidity or its correlation with age. Continuous efforts are being made to explore these arenas, which could lead to the development of new and more effective drugs.

Further, the report states that one of the major challenges affecting the market growth is the entry of generic drugs. The introduction of generic drugs will lead to price wars among vendors and to price erosion. The patent expiry of leading brands will also significantly impact the growth of the market during the forecast period. This will lead to considerable losses for the manufacturing and marketing vendors and inhibit the growth of the market as the prices of the drugs need to be reduced considerably.

The key vendors dominating this space include:

  • AbbVie Inc.
  • Auxilium Pharmaceuticals Inc.
  • Actavis Inc.
  • Eli Lilly & Co.
  • Endo Health Solutions Inc.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Market Research Methodology

05. Scope of the Report

06. Market Landscape

07. Geographical Segmentation

08. Rate of Incidence and Prevalence

09. Vendor Landscape

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/jh692m/global

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals